Aptar Pharma Partners with Pulmotree to Develop Kolibri NPLI Platform
As part of the agreement, Aptar Pharma will provide PULMOTREE with their full support to accelerate growth, be the main point of contact for customers, and have the ability to complement the Kolibri NPLI Platform Technology with Aptar’s suite of comprehensive services.
Drug Developers | 10/09/2024 | By Aishwarya
Kiora Receives Grant from CRF for Clinical Trial Endpoints for Inherited Retinal Diseases
Kiora Pharmaceuticals has secured grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for patients with profound blindness.
Drug Developers | 15/04/2024 | By Aishwarya | 117
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy